The structural diversity of psychedelic drug actions revealed

There is currently a resurgence in exploring the utility of classical psychedelics to treat depression, addiction, anxiety disorders, cluster headaches, and many other neuropsychiatric disorders. A biological target of these compounds, and a hypothesized target for their therapeutic actions, is the 5-HT<sub>2A</sub> serotonin receptor. Here, we present 7 cryo-EM structures covering all major compound classes of psychedelic and non-psychedelic agonists, including a β-arrestin-biased compound RS130-180. Identifying the molecular interactions between various psychedelics and the 5-HT<sub>2A</sub> receptor reveals both common and distinct motifs among the examined psychedelic chemotypes. These findings lead to a broader mechanistic understanding of 5-HT<sub>2A</sub> activation, which can catalyze the development of novel chemotypes with potential therapeutic utility and fewer side effects.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-03-19
DOI
https://doi.org/10.1038/s41467-025-57956-7
Citations
25
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
57.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The structural diversity of psychedelic drug actions revealed

Bryan L. Roth, Ning Sun, H. Ümit Kanıskan, Kuglae Kim et al.
25 citations
Nature Communications
Psychedelics and Drug Studies
57.67
article

The structural diversity of psychedelic drug actions revealed

Bryan L. Roth, Ning Sun, H. Ümit Kanıskan, Kuglae Kim, Nicholas J. Kapolka, Jian Jun Jin, Renhong Sun, Ryan H. Gumpper, Zhongli Xu, Jonathan F. Fay, Jeffrey F. DiBerto, B. Krumm, Manish K. Jain, David E. Nichols
article en
25 citations

Abstract

There is currently a resurgence in exploring the utility of classical psychedelics to treat depression, addiction, anxiety disorders, cluster headaches, and many other neuropsychiatric disorders. A biological target of these compounds, and a hypothesized target for their therapeutic actions, is the 5-HT<sub>2A</sub> serotonin receptor. Here, we present 7 cryo-EM structures covering all major compound classes of psychedelic and non-psychedelic agonists, including a β-arrestin-biased compound RS130-180. Identifying the molecular interactions between various psychedelics and the 5-HT<sub>2A</sub> receptor reveals both common and distinct motifs among the examined psychedelic chemotypes. These findings lead to a broader mechanistic understanding of 5-HT<sub>2A</sub> activation, which can catalyze the development of novel chemotypes with potential therapeutic utility and fewer side effects.

Nature CommunicationsVol. 16(1)
University of North Carolina at Chapel Hill (US), University of Maryland, Baltimore (US), Yonsei University (KR), Zen Bio (United States) (US), Icahn School of Medicine at Mount Sinai (US)
Defense Advanced Research Projects Agency, National Institute on Drug Abuse
Good health and well-being
Openalex Percentile: Top 0%
Psychedelics and Drug Studies
57.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.